ClinConnect ClinConnect Logo
Search / Trial NCT06817252

How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes

Launched by UNIVERSITY OF NEVADA, LAS VEGAS · Feb 7, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

White Potato Prediabetes Mediterranean Diet Cardiometabolic Health Dietary Quality

ClinConnect Summary

This clinical trial is exploring how a Mediterranean diet that includes baked potatoes with the skin can affect heart and metabolic health in adults who have pre-diabetes. Researchers want to find out if adding these potatoes and nutrition education can help improve blood sugar levels, heart health, and overall diet quality in participants. They will compare those who follow this enhanced diet plan to those who follow the Mediterranean diet alone to see if the addition of baked potatoes makes a difference.

To participate, you need to be between 45 and 80 years old, live in the Las Vegas/Henderson area, and meet certain health criteria, such as having a specific blood sugar level and body mass index (BMI). If you join, you'll come to the study site for screenings and regular check-ups over 12 weeks to track your health progress and receive guidance on diet. You’ll also keep a record of what you eat during this time. If you're chosen for the group that includes baked potatoes, you'll receive these potatoes every three weeks. It's important to note that some people, like those with certain health conditions or those on specific medications, won't be eligible to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Men and postmenopausal women within the Las Vegas/Henderson NV area
  • Ages 45-80 years
  • BMI between 25-40 kg/m2
  • Fasting blood glucose between 100-126 g/dL, HbA1c between 5.7-6.4%
  • Individuals from different demographic backgrounds (i.e., American Indian or Alaska Native, Caucasians, Asian, Black or African-American, Native Hawaiian, Hispanic, Latino or Pacific Islander)
  • Individuals who are considered "non-frequent" white potato consumers (\<2 servings of baked potatoes/week)
  • Individuals from all races, genders, sexual identities, and religions will be included
  • Individuals must follow certain guidelines, including avoiding new medications during the study or significant changes to lifestyle factors (e.g. beginning to smoke or exercise more or less than usual)
  • Exclusion Criteria:
  • Individuals with uncontrolled hypertension (≥160/100mmHg), active cancer, asthma, thyroid, kidney, liver, or pancreatic diseases
  • Individuals who are currently using insulin, on dialysis, changing/adding hypoglycemic, anti-hypertensive, and hypocholesterolemic medication within ≤3 months (or throughout the study)
  • Individuals participating in weight loss programs or another clinical trial
  • Individuals who start smoking
  • Individuals who have unstable metabolic or chronic diseases
  • Individuals who may have allergies to potatoes
  • Woman who are currently pregnant, think they may be pregnant, or who is nursing cannot participate (women must be postmenopausal)

About University Of Nevada, Las Vegas

The University of Nevada, Las Vegas (UNLV) is a prominent research institution committed to advancing healthcare through innovative clinical trials. With a focus on multidisciplinary collaboration, UNLV engages in rigorous scientific inquiry to explore new treatments and interventions that address pressing health challenges. The university's dedicated faculty and state-of-the-art facilities foster an environment conducive to cutting-edge research, ensuring the highest standards of ethical practice and patient care. Through its clinical trials, UNLV aims to contribute to the body of medical knowledge while improving health outcomes for diverse populations.

Locations

Las Vegas, Nevada, United States

Las Vegas, Nevada, United States

Patients applied

0 patients applied

Trial Officials

Neda S Akhavan, PhD, RD

Principal Investigator

University of Nevada, Las Vegas

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported